Pure Gold: CRI Receives Highest Seal from GuideStar
March 21, 2014 |
We were thrilled to learn recently that the Cancer Research Institute has been listed as a gold participant by the GuideStar Exchange for our commitment to transparency, accountability, and reporting. The Gold Seal is reserved for charities that not only provide full information about governance and finances, but also describe mission objectives, progress, and impact—all important considerations for anyone wishing to support a worthy cause.
GuideStar is a neutral, nonprofit organization that synthesizes and publishes public information on registered 501(c)3s, like CRI, in an effort to advance transparency and enable donors to make better decisions about their charitable giving. This top-level recognition of CRI’s participation in GuideStar’s charity review program accompanies our other top designations from charity and business “watchdogs,” including:
4 out of 4 star review from Charity Navigator, the nation’s largest and most utilized evaluator of charities
“A” rating from CharityWatch, formerly the American Institute of Philanthropy—CRI is one out of only a handful of cancer charities to receive this distinction, and is the only highly-rated charity dedicated to cancer immunology.
The Better Business Bureau's Wise Giving Alliance, which offers the most comprehensive analysis of U.S. charities, says Cancer Research Institute exceeds or meets all of its 20 Standards for Charity Accountability.
Since our founding over 60 years ago, Cancer Research Institute has upheld the highest standards of fiscal responsibility coupled with strategic, high-impact investment in life-saving research. When you give to CRI, you can be sure your charitable investment will be spent wisely and will make the most difference possible in our efforts to conquer cancer together